EnGeneIC Information

View Top Employees from EnGeneIC

EngeneIC is a biopharmaceutical company focused on developing its proprietary EDV™ nanocell platform for the targeted delivery of chemotherapeutics and functional nucleic acids in cancer. The EDV™ is a first-in-class Cyto-Immunotherapy platform.

Website	http://engeneic.com/
Revenue	$5.2 million
Funding	$18 million
Employees	60 (8 on RocketReach)
Founded	2001
Address	11 Julius Avenue, Level 4, North Ryde, New South Wales 2113, AU
Phone	+61 2 9420 5844
Technologies	JavaScript , HTML , PHP +13 more (view full list)
Industry	Biotechnology, Pharmaceuticals, Biotechnology Research, Drug Discovery, Science and Engineering, Healthcare, Life Science, Therapeutics, Health Care
Web Rank	17 Million
Keywords	Cancer Therapeutics, Targeted Drug Delivery, Drug Delivery Platform, Nanomedicine, New Drug Delivery, Chemotherapy, Immunotherapy, Oncology, Cancer Treatment, Pharmaceutical Development, Innovative Therapies, Advanced Therapies, Personalized Medicine, Molecular Medicine, Clinical Trials
Competitors	Johnson & Johnson, Roche, Merck & Co., Inc., Pfizer, Sanofi, GSK, AstraZeneca, Bristol Myers Squibb, Genentech, Amgen +43 more (view full list)
SIC	SIC Code 283 Companies, SIC Code 28 Companies, SIC Code 80 Companies
NAICS	NAICS Code 541 Companies, NAICS Code 54171 Companies, NAICS Code 54 Companies, NAICS Code 5417 Companies, NAICS Code 541711 Companies